Acute Lymphoblastic Leukemia in Remission Clinical Trials

23 clinical trials for Acute Lymphoblastic Leukemia in Remission across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Personalized NK Cell Therapy in CBT — RECRUITING · PHASE2
• 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome — RECRUITING · PHASE1
• MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing — RECRUITING · NA
• Combination Chemotherapy and Inotuzumab Ozogamicin in Treating Patients With B Acute Lymphoblastic Leukemia — TERMINATED · PHASE2
• Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients Previously Infected With CMV and Undergoing Donor Hematopoietic Cell Transplant — ACTIVE_NOT_RECRUITING · PHASE2
• Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome — SUSPENDED · PHASE1
• Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD — COMPLETED · PHASE2
• CMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic Transplant — ACTIVE_NOT_RECRUITING · PHASE1
• Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion — ACTIVE_NOT_RECRUITING · NA
• Matched Unrelated vs. Haploidentical Donor for Allogeneic Stem Cell Transplantation in Patients With Acute Leukemia — ACTIVE_NOT_RECRUITING · PHASE2
• Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab — WITHDRAWN · PHASE2
• Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma — COMPLETED · PHASE2
• Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant — COMPLETED · PHASE2
• CD19 Chimeric Antigen Receptors and CD19 Positive Feeder T Cells as a Leukemia Consolidation Treatment — OTHER · PHASE1
• Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies — TERMINATED · PHASE2
• Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation — COMPLETED · PHASE1
• Fludarabine Phosphate, Clofarabine, and Busulfan With Vorinostat in Treating Patients With Acute Leukemia in Remission or Relapse Undergoing Donor Stem Cell Transplant — COMPLETED · PHASE1
• Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes — COMPLETED · PHASE2
• Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation — WITHDRAWN · PHASE2
• VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies — COMPLETED · PHASE1
• NK Cells in Cord Blood Transplantation — OTHER · PHASE1
• Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell Transplant — WITHDRAWN · PHASE2
• Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer — COMPLETED · PHASE3

Refine this search